Effects of alkalization therapy in metastatic or recurrent pancreatic cancer: a case-control study

Effects of alkalization therapy in metastatic or recurrent pancreatic cancer: a case-control study - Effects of alkalization therapy in metastatic or recurrent pancreatic cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036126

Enrollment

200

Registered

2019-03-11

Start date

2018-12-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Intervention group: Metastatic or recurrent pancreatic cancer patients who treated with alkalization therapy consisting of alkaline diet and bicarbonate Control group: Metastatic or recurrent pancreatic cancer patients who did not receive alkalization therapy

Exclusion criteria

Exclusion criteria: Patients who refused to participate the study by opt-out.

Design outcomes

Primary

Measure	Time frame
Overall survival (OS)	—

Countries

Japan

Contacts

Public ContactReo Hamaguchi

Karasuma Wada Clinic Oncology

reo-h@nifty.com075-213-0080

Outcome results